Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is dismal. A recent experimental treatment …
Every year Stanford University publishes a list of highly cited scientists based on citation metrics from Scopus. The list for …
Here’s part 3 of the N2CR Cancer Researchers’ Stories! Let’s get to know Professor Shazib Pervaiz, who is part of …